HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCCAM Future Grants May Focus More On Mind-Body, Less On Herbals

This article was originally published in The Tan Sheet

Executive Summary

The National Center for Complementary & Alternative Medicine is considering shifting a greater percentage of its funding portfolio toward mind-body medicine and away from herbal medicines

You may also be interested in...



Washington In Brief

Burton gets subcommittee chair: Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights, Committee Chair Tom Davis (R-Va.) announces Jan. 31. Subcommittee will address issues concerning public health policy, human rights and family health, according to Davis' office. Votes to confirm the subcommittee and chairman appointment will be taken when the full Government Reform Committee convenes, possibly the week of Feb. 10. In his new position, Burton likely will revisit dietary supplement-related issues, which were the subject of frequent hearings during his tenure as full committee chair...

Probiotics Research Initiative Spurs Debate On NCCAM’s Pediatrics Role

Research on probiotics for prevention and treatment of pediatric illness is not a high enough priority for U.S. children to justify National Center for Complementary & Alternative Medicine funding, an NCCAM advisory council member maintained

NCCAM PC-SPES Clinical Research Could Resume With “Clean” Product

NIH's National Center for Complementary & Alternative Medicine could resume funding clinical research on PC-SPES if an independent manufacturer is able to develop an uncontaminated version of the proprietary herbal blend, NCCAM Director Stephen Straus, MD, suggested at the center's advisory council meeting in Rockville, Md. Aug. 26

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel